These findings are consistent with our gene enrichment analysis results, indicating that AKR1B10 may affect the biological characteristics of HCC by regulating inflammation-related signaling pathways, thereby affecting tumor development and patient prognosis. Here, AKR1B10 is linked to hepatocellular carcinoma.